Delivery Order SPE2DB24D1205-SPE2DB25FDACC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,926.00 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ml syringes. Issued on July 29, 2025, with an ultimate completion date of July 30, 2025, this firm fixed-price delivery order represents a competitively awarded procurement with no set-aside designation. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $6,337.95 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5 mL syringe format. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a $92,004.02 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ML syringes under a firm fixed-price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This competitively awarded delivery order carries no set-aside designation and falls under AmerisourceBergen's existing contract vehicle with DLA....
- The Defense Logistics Agency awarded a $46,889.08 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. This firm fixed price contract, which is not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract...
- The Defense Logistics Agency awarded a $4,901.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ml syringes, with an ultimate completion date of August 1, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $23,429.21 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This non-competitive, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine procurement under the company's larger relationship with the...
- The Defense Logistics Agency awarded a $26,021.15 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccines in 0.5 mL syringe format on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $17,569.56 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5mL), with performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,990.43 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a $78,798.85 delivery order to AmerisourceBergen Drug Corp for Prevnar 20 vaccine in 0.5ML syringes, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDACCDelivery Order
The Defense Logistics Agency awarded a $6,752.85 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This competitively awarded, firm fixed price contract has a completion date of September 4, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical distribution operations. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's role as a prime vendor reflects its significant capability as a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for the Defense Health Agency and U.S. Coast Guard, with consistent delivery of diverse pharmaceutical products across multiple therapeutic domains through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/3/25 |